spacer
home > > winter 2020 > paving the way
PUBLICATIONS


Paving the Way



Over the last few decades, there have been more new drug launches than ever before, with a recordbreaking 59 approvals by the FDA in 2018 (1). This has, in part, been fueled by the shift to treatments customised for rare diseases and personalised medicines, which accounted for 42% of all approvals last year (2). The pace of innovation has accelerated as researchers and scientists challenge the frontiers of genomics, microbiology, and diagnostics, contributing to a dramatic rise in the number of trials demanded in the growing life science industry (3).

However, while breakthroughs continue to be made, the path to bring new medicines to market has not shortened. In fact, the drug development process has become increasingly complex, and the pace of trials is slow (4). Finding targeted patient populations and investigators to participate in trials is difficult as sponsor companies compete to collect more and more clinical research data, much of which is difficult and time-consuming to measure (5).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Rik Van Mol is Vice President, Cloud Strategy, at Veeva Systems with over 20 years of experience in both management consulting and cloud software in the life science/pharma sector. Rik’s experience has been built in assisting clients through complex transformation programmes across the life sciences value chain for most of the world’s largest companies. Rik is a recognised thought leader in the industry with deep expertise in architecting, launching, and implementing innovative and industryleading strategies and solutions.
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

White Papers
 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement